These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 9564877)
1. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Wang J; Niu W; Witte DP; Chernausek SD; Nikiforov YE; Clemens TL; Sharifi B; Strauch AR; Fagin JA Endocrinology; 1998 May; 139(5):2605-14. PubMed ID: 9564877 [TBL] [Abstract][Full Text] [Related]
2. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. Wang J; Niu W; Nikiforov Y; Naito S; Chernausek S; Witte D; LeRoith D; Strauch A; Fagin JA J Clin Invest; 1997 Sep; 100(6):1425-39. PubMed ID: 9294108 [TBL] [Abstract][Full Text] [Related]
3. The alpha-smooth muscle actin promoter: a useful tool to analyse autocrine and paracrine roles of mesenchymal cells in normal and diseased bowel. Lund PK Gut; 1998 Mar; 42(3):320-2. PubMed ID: 9577334 [TBL] [Abstract][Full Text] [Related]
4. Targeted expression of a protease-resistant IGFBP-4 mutant in smooth muscle of transgenic mice results in IGFBP-4 stabilization and smooth muscle hypotrophy. Zhang M; Smith EP; Kuroda H; Banach W; Chernausek SD; Fagin JA J Biol Chem; 2002 Jun; 277(24):21285-90. PubMed ID: 11923290 [TBL] [Abstract][Full Text] [Related]
5. Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences. March KL; Sandusky G; Fan L Oncogene; 1999 Jun; 18(25):3773-82. PubMed ID: 10391686 [TBL] [Abstract][Full Text] [Related]
6. Cellular localization and sex steroid regulation of insulin-like growth factor binding protein messenger ribonucleic acids in the primate myometrium. Adesanya OO; Zhou J; Bondy CA J Clin Endocrinol Metab; 1996 Jul; 81(7):2495-501. PubMed ID: 8675566 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal IGF-I overexpression: paracrine effects in the intestine, distinct from endocrine actions. Williams KL; Fuller CR; Fagin J; Lund PK Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G875-85. PubMed ID: 12223347 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Hoeflich A; Wu M; Mohan S; Föll J; Wanke R; Froehlich T; Arnold GJ; Lahm H; Kolb HJ; Wolf E Endocrinology; 1999 Dec; 140(12):5488-96. PubMed ID: 10579311 [TBL] [Abstract][Full Text] [Related]
9. Smooth muscle-targeted overexpression of insulin-like growth factor I results in enhanced vascular contractility. Zhao G; Sutliff RL; Weber CS; Wang J; Lorenz J; Paul RJ; Fagin JA Endocrinology; 2001 Feb; 142(2):623-32. PubMed ID: 11159833 [TBL] [Abstract][Full Text] [Related]
10. Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors. Cohick WS; Gockerman A; Clemmons DR J Cell Physiol; 1993 Oct; 157(1):52-60. PubMed ID: 7691836 [TBL] [Abstract][Full Text] [Related]
11. Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA. Provenzano AP; Besner GE; James PF; Harding PA Growth Factors; 2005 Mar; 23(1):19-31. PubMed ID: 16019424 [TBL] [Abstract][Full Text] [Related]
12. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth. Gay E; Seurin D; Babajko S; Doublier S; Cazillis M; Binoux M Endocrinology; 1997 Jul; 138(7):2937-47. PubMed ID: 9202238 [TBL] [Abstract][Full Text] [Related]
13. Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Hoeflich A; Nedbal S; Blum WF; Erhard M; Lahm H; Brem G; Kolb HJ; Wanke R; Wolf E Endocrinology; 2001 May; 142(5):1889-98. PubMed ID: 11316754 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor (IGF) II induced changes in expression of IGF binding proteins in lymphoid tissues of hIGF-II transgenic mice. Smink JJ; Koster JG; Hendriks-Stegeman BI; Van Buul-Offers SC Endocrinology; 1999 Dec; 140(12):5876-82. PubMed ID: 10579353 [TBL] [Abstract][Full Text] [Related]
15. Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5. Rutter MM; Markoff E; Clayton L; Akeno N; Zhao G; Clemens TL; Chernausek SD Bone; 2005 Feb; 36(2):224-31. PubMed ID: 15780948 [TBL] [Abstract][Full Text] [Related]
16. Smooth muscle overexpression of IGF-I induces a novel adaptive response to small bowel resection. Knott AW; Juno RJ; Jarboe MD; Profitt SA; Erwin CR; Smith EP; Fagin JA; Warner BW Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G562-70. PubMed ID: 15142831 [TBL] [Abstract][Full Text] [Related]
17. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Sanz S; Pucilowska JB; Liu S; Rodríguez-Ortigosa CM; Lund PK; Brenner DA; Fuller CR; Simmons JG; Pardo A; Martínez-Chantar ML; Fagin JA; Prieto J Gut; 2005 Jan; 54(1):134-41. PubMed ID: 15591519 [TBL] [Abstract][Full Text] [Related]
18. Expression of insulin-like growth factor binding protein-4, insulin-like growth factor-I receptor, and insulin-like growth factor-I in the mouse uterus throughout the estrous cycle. Henemyre C; Markoff E Mol Reprod Dev; 1999 Apr; 52(4):350-9. PubMed ID: 10092114 [TBL] [Abstract][Full Text] [Related]
19. Development of smooth muscle hypertrophy is closely associated with increased gene expression of insulin-like growth factor binding protein-2 and -4. Chen Y; Arner A; Bornfeldt KE; Uvelius B; Arnqvist HJ Growth Regul; 1995 Mar; 5(1):45-52. PubMed ID: 7538370 [TBL] [Abstract][Full Text] [Related]
20. Targeted disruption of the pregnancy-associated plasma protein-A gene is associated with diminished smooth muscle cell response to insulin-like growth factor-I and resistance to neointimal hyperplasia after vascular injury. Resch ZT; Simari RD; Conover CA Endocrinology; 2006 Dec; 147(12):5634-40. PubMed ID: 16959843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]